Donna Smith

666 total citations
12 papers, 379 citations indexed

About

Donna Smith is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Donna Smith has authored 12 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Reproductive Medicine and 3 papers in Molecular Biology. Recurrent topics in Donna Smith's work include Ovarian cancer diagnosis and treatment (4 papers), T-cell and Retrovirus Studies (3 papers) and Animal Disease Management and Epidemiology (2 papers). Donna Smith is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), T-cell and Retrovirus Studies (3 papers) and Animal Disease Management and Epidemiology (2 papers). Donna Smith collaborates with scholars based in United States and United Kingdom. Donna Smith's co-authors include Baoguang Wang, Catharie C. Nass, Gregorio Delgado, Tzong‐Hae Lee, Daniel M. Chafets, A. Bennett Jenson, Attila T. Lörincz, Willard A. Barnes, Susan W. Ahmed and Robert J. Kurman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Donna Smith

12 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Smith United States 8 159 138 130 111 93 12 379
Shoko Miura Japan 15 261 1.6× 65 0.5× 26 0.2× 24 0.2× 434 4.7× 48 922
P. Le Bouteiller France 16 794 5.0× 43 0.3× 177 1.4× 3 0.0× 177 1.9× 32 898
Sylvie Bruel France 9 354 2.2× 44 0.3× 71 0.5× 49 0.5× 12 499
Yasushi Sawayama Japan 13 222 1.4× 36 0.3× 94 0.7× 124 1.1× 54 450
Maria Grazia Ferrari United States 8 164 1.0× 42 0.3× 89 0.7× 76 0.7× 13 321
M. Glaucia Teixeira United States 6 233 1.5× 8 0.1× 207 1.6× 5 0.0× 16 0.2× 8 347
Layale Yaghi France 8 414 2.6× 27 0.2× 113 0.9× 70 0.8× 10 477
J.‐G. Zhang China 6 338 2.1× 27 0.2× 74 0.6× 47 0.5× 6 386
Gill Ps United States 9 180 1.1× 34 0.2× 85 0.7× 87 0.8× 17 342
Victor Bakels Netherlands 8 72 0.5× 307 2.2× 8 0.1× 4 0.0× 7 0.1× 8 485

Countries citing papers authored by Donna Smith

Since Specialization
Citations

This map shows the geographic impact of Donna Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Smith more than expected).

Fields of papers citing papers by Donna Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Smith. The network helps show where Donna Smith may publish in the future.

Co-authorship network of co-authors of Donna Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Smith. A scholar is included among the top collaborators of Donna Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Smith. Donna Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Lyons, John F., Steven J. Woodhead, Ruth E. Feltell, et al.. (2007). AT13148, an orally bioavailable AKT kinase inhibitor with potent anti-tumor activity in both in vitro and in vivo models exhibiting AKT pathway deregulation.. Molecular Cancer Therapeutics. 6. 2 indexed citations
3.
Squires, Matthew, Ruth E. Feltell, Victoria Lock, et al.. (2007). AT7519, a Potent CDK Inhibitor, Is Active in Leukemia Models and Primary CLL Patient Samples.. Blood. 110(11). 3127–3127. 2 indexed citations
4.
Wang, Baoguang, Donna Smith, Catharie C. Nass, et al.. (2005). A Prospective Study of Sexual Transmission of Human T Lymphotropic Virus (HTLV)–I and HTLV‐II. The Journal of Infectious Diseases. 191(9). 1490–1497. 85 indexed citations
5.
6.
Wang, Baoguang, David J. Wright, Catharie C. Nass, et al.. (2004). Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study. Retrovirology. 1(1). 4–4. 22 indexed citations
7.
Werner‐Wasik, Maria, et al.. (1995). Prognostic factors for local and distant recurrence in Stage I and II cervical carcinoma. International Journal of Radiation Oncology*Biology*Physics. 32(5). 1309–1317. 64 indexed citations
8.
Asbury, Robert F., John A. Blessing, Donna Smith, & Linda F. Carson. (1995). Aminothiadiazole in the Treatment of Advanced Leiomyosarcoma of the Uterine Corpus. American Journal of Clinical Oncology. 18(5). 397–399. 15 indexed citations
9.
Manetta, Alberto, John A. Blessing, William J. Mann, & Donna Smith. (1995). A Phase II Study of Fazarabine (NSC 281272) In Patients with Advanced Squamous Cell Carcinoma of the Cervix. American Journal of Clinical Oncology. 18(5). 439–440. 7 indexed citations
10.
Smith, Donna, et al.. (1989). Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas. American Journal of Obstetrics and Gynecology. 161(4). 911–915. 11 indexed citations
11.
Barnes, Willard A., Gregorio Delgado, Robert J. Kurman, et al.. (1988). Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecologic Oncology. 29(3). 267–273. 116 indexed citations
12.
Faras, Anthony J., Richard A. Krzyzek, Ronald S. Ostrow, et al.. (1980). GENETIC VARIATION AMONG PAPILLOMAVIRUSES*. Annals of the New York Academy of Sciences. 354(1). 60–79. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoko Miura Breakdown of academic impact, for papers by P. Le Bouteiller Breakdown of academic impact, for papers by Sylvie Bruel Breakdown of academic impact, for papers by Yasushi Sawayama Breakdown of academic impact, for papers by Maria Grazia Ferrari Breakdown of academic impact, for papers by M. Glaucia Teixeira Breakdown of academic impact, for papers by Layale Yaghi Breakdown of academic impact, for papers by J.‐G. Zhang Breakdown of academic impact, for papers by Gill Ps Breakdown of academic impact, for papers by Victor Bakels
Rankless by CCL
2026